UNSPSC 51191549: Frusemide or furosemide

This classification denotes a loop diuretic with the molecular formula C12H11ClN2O5S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 7LXU5N7ZO5, chemically known as benzoic acid, 5-(aminosulfonyl)-4-chloro-2-((2-furanylmethyl)amino)- but generally known as furosemide, which bears US NIH Compound Identifier 3440. European Medicines Agency schedules Furosemide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07849MIG. The term FUROSEMIDE is an International Non-Proprietary Name.

UNSPSC 51191549 Frusemide or furosemide is a Commodity code representing pharmaceutical products procured by state and local governments for use in health care facilities, correctional institutions, and public health programs. The recent opportunities block shows a clear mismatch: the posted solicitations tag chemicals for water treatment (sodium bisulfite) and multi-source generic pharmaceuticals under this furosemide code, indicating either classification drift or category misalignment in the state and local systems that posted them. The actual scope of work under this code when properly applied covers loop diuretic medications used in treatment protocols across public health and correctional settings.

The issuing bodies in the recent records include the City of Meriden, Connecticut (municipal water facility procurement) and the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, serving participating state and local government facilities including Oregon. The Minnesota RFP, posted January 20, 2026 with proposals due March 26, 2026, solicits generic multi-source pharmaceuticals and OTC products through authorized wholesalers (AmerisourceBergen Drug Corporation/Cencora, Cardinal Health 110 and 112, and Morris & Dickson Co., LLC), with awarded contracts effective July 1, 2026. The Connecticut solicitation (B027-15), posted July 8, 2026 with bids due July 29, 2026, targets sodium bisulfite for a Water Pollution Control Facility — work plainly outside pharmaceutical scope. The code shows active recent procurement in Minnesota and Connecticut; however, the current opportunities block reflects significant category misclassification that obscures true furosemide and loop-diuretic solicitation patterns under this code.